Innovations in Adolescent Depression Treatment

This chapter explores the advancements in Transcranial Magnetic Stimulation (TMS) as a promising non-drug treatment for adolescent depression, emphasizing its recent FDA approval for ages 15 and over. The discussion also highlights prescription digital therapies, including Rejoin, and the importance of screening for bipolar disorder to enhance treatment outcomes. Additionally, it covers new psychopharmacological developments and their implications for mental health, particularly focusing on mood disorders and cognitive function research.